window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

NSCLC

  • Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain,Research & Development

    First UK patient dosed in personalised lung cancer vaccine trial using Touchlight DNA technology

    The first UK patient has been dosed with a personalised [...]

    July 30, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Kairos Pharma and Bayer to evaluate ENV-105 combination in prostate cancer

    Kairos Pharma and Bayer will evaluate ENV-105 in combination with [...]

    July 23, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Research & Development,Therapeutic Areas

    Kairos reports positive interim Phase 1 safety data for ENV-105 in EGFR-mutated lung cancer

    Kairos Pharma has reported positive interim safety results from an [...]

    July 16, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Erasca reports encouraging Phase 1 data for ERAS-0015 and outlines Phase 3 cancer trials

    Erasca has reported updated preliminary Phase 1 data for its [...]

    July 14, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Evogene partners QUT on AI drug discovery for lung cancer resistance

    Evogene Ltd has partnered with Queensland University of Technology to [...]

    May 5, 2026
  • Uncategorised

    MaaT Pharma randomizes first patient in IMMUNOLIFE Phase 2 NSCLC microbiome study

    MaaT Pharma has randomized the first patient in the IMMUNOLIFE [...]

    January 21, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Cemiplimab plus chemotherapy shows five-year survival benefit in advanced NSCLC Empower-lung 3 trial

    Regeneron UK Limited has reported five-year follow-up results from the [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Gericke launches continuous manufacturing platform for pharmaceutical production
    Categories: Manufacturing & Supply Chain
  • Aurora Cannabis acquires UK medical cannabis importer and pharmacy
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
  • Dunbar Pharma brings plant-derived dronabinol API to UK through IPS Pharma
    Categories: Clinical & Regulatory, Drug Delivery & Formulation, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top